financetom
Business
financetom
/
Business
/
Wells Fargo Names Fernando Rivas Sole CEO of CIB Unit as Jon Weiss Steps Down
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wells Fargo Names Fernando Rivas Sole CEO of CIB Unit as Jon Weiss Steps Down
Jan 30, 2025 7:02 AM

09:38 AM EST, 01/30/2025 (MT Newswires) -- Wells Fargo ( WFC ) said Thursday that Fernando Rivas will become the sole chief executive of its Corporate & Investment Banking, or CIB, division as Jon Weiss steps down immediately and plans to retire on June 1.

Weiss has been with the company for about 20 years, Wells Fargo ( WFC ) said.

Rivas joined Wells Fargo ( WFC ) in May 2024 as CIB's co-CEO and will now lead the unit alone, the company added.

Price: 78.97, Change: +0.60, Percent Change: +0.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Municipal Bond Offerings This Week See High Flood and Wildfire Scores
Municipal Bond Offerings This Week See High Flood and Wildfire Scores
Mar 25, 2024
09:19 AM EDT, 03/25/2024 (MT Newswires) -- Multiple municipal bond offerings this week have a high exposure to climate risk, specifically high Flood and Wildfire Scores, according to ICE Climate Data. A $5 million offering from Seaside Park, N.J., records a Flood Score of 5.0 out of 5.0, ICE reports. Locations with a component Physical Climate Risk Score, which includes...
CrowdStrike Holdings Insider Sold Shares Worth $25,515,133, According to a Recent SEC Filing
CrowdStrike Holdings Insider Sold Shares Worth $25,515,133, According to a Recent SEC Filing
Mar 25, 2024
09:25 AM EDT, 03/25/2024 (MT Newswires) -- George Kurtz, Director, PRESIDENT AND CEO, on March 21, 2024, sold 78,080 shares in CrowdStrike Holdings ( CRWD ) for $25,515,133. Following the Form 4 filing with the SEC, Kurtz has control over a total of 1,148,102 shares of the company, with 1,148,102 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1535527/000141588924009014/xslF345X03/form4-03222024_060312.xml Price: 325.5, Change: -2.08,...
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
Mar 25, 2024
Friday, the FDA approved broad new label expansions for Esperion Therapeutics Inc’s NEXLETOL (bempedoic acid) Tablets and NEXLIZET (bempedoic acid and ezetimibe) Tablets based on CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded LDL-C lowering in primary and secondary prevention patients.  In addition, the enhanced labels support using NEXLETOL and NEXLIZET alone or in combination with statins.  They also...
Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell
Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell
Mar 25, 2024
09:20 AM EDT, 03/25/2024 (MT Newswires) -- Dyne Therapeutics ( DYN ) said Monday its President and Chief Executive Joshua Brumm has stepped down to pursue a career in healthcare investing, effective immediately. The clinical-stage muscle disease company has named John Cox as Brumm's successor. Brumm will remain with the company as an advisor to help with the transition. Cox...
Copyright 2023-2026 - www.financetom.com All Rights Reserved